These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 8843906

  • 21. Adoptive transfer of experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein.
    Kawashima H, Fujiño Y, Mochizuki M.
    Jpn J Ophthalmol; 1991; 35(1):51-60. PubMed ID: 1895569
    [Abstract] [Full Text] [Related]

  • 22. Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations.
    Kerr EC, Raveney BJ, Copland DA, Dick AD, Nicholson LB.
    J Autoimmun; 2008 Dec; 31(4):354-61. PubMed ID: 18838247
    [Abstract] [Full Text] [Related]

  • 23. High mobility group box protein-1 in experimental autoimmune uveoretinitis.
    Watanabe T, Keino H, Sato Y, Kudo A, Kawakami H, Okada AA.
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2283-90. PubMed ID: 19151394
    [Abstract] [Full Text] [Related]

  • 24. Functional studies of major histocompatibility class II-positive dendritic cells and resident tissue macrophages isolated from the rat iris.
    Steptoe RJ, Holt PG, McMenamin PG.
    Immunology; 1995 Aug; 85(4):630-7. PubMed ID: 7558159
    [Abstract] [Full Text] [Related]

  • 25. The behaviour of ED1- and ED2-positive cells in the rat iris and choroid following penetrating keratoplasty and cyclosporin A therapy.
    Krause L, Coupland SE, Hoffmann F.
    Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S149-58. PubMed ID: 8871167
    [Abstract] [Full Text] [Related]

  • 26. The blood-retinal barrier in experimental autoimmune uveoretinitis. Leukocyte interactions and functional damage.
    Greenwood J, Howes R, Lightman S.
    Lab Invest; 1994 Jan; 70(1):39-52. PubMed ID: 8302017
    [Abstract] [Full Text] [Related]

  • 27. Marrow-derived activated macrophages are required during the effector phase of experimental autoimmune uveoretinitis in rats.
    Forrester JV, Huitinga I, Lumsden L, Dijkstra CD.
    Curr Eye Res; 1998 Apr; 17(4):426-37. PubMed ID: 9561835
    [Abstract] [Full Text] [Related]

  • 28. Role of retinal pigment epithelium in the development of experimental autoimmune uveitis.
    Konda BR, Pararajasegaram G, Wu GS, Stanforth D, Rao NA.
    Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):40-7. PubMed ID: 8300362
    [Abstract] [Full Text] [Related]

  • 29. Ultrastructural and immunocytochemical studies of smooth muscle cells in iris arterioles of rats with experimental autoimmune uveoretinitis.
    Wang J, Essner E, Shichi H.
    Exp Mol Pathol; 1994 Dec; 61(3):153-63. PubMed ID: 7601268
    [Abstract] [Full Text] [Related]

  • 30. Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming.
    Sartani G, Silver PB, Rizzo LV, Chan CC, Wiggert B, Mastorakos G, Caspi RR.
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2211-8. PubMed ID: 8843907
    [Abstract] [Full Text] [Related]

  • 31. Immunohistochemical analysis of the rat central nervous system during experimental allergic encephalomyelitis, with special reference to Ia-positive cells with dendritic morphology.
    Matsumoto Y, Hara N, Tanaka R, Fujiwara M.
    J Immunol; 1986 May 15; 136(10):3668-76. PubMed ID: 3084638
    [Abstract] [Full Text] [Related]

  • 32. Ultrastructural pathology of experimental autoimmune uveitis. Quantitative evidence of activation and possible high endothelial venule-like changes in retinal vascular endothelium.
    McMenamin PG, Forrester JV, Steptoe RJ, Dua HS.
    Lab Invest; 1992 Jul 15; 67(1):42-55. PubMed ID: 1625447
    [Abstract] [Full Text] [Related]

  • 33. Mitochondrial oxidative DNA damage in experimental autoimmune uveitis.
    Khurana RN, Parikh JG, Saraswathy S, Wu GS, Rao NA.
    Invest Ophthalmol Vis Sci; 2008 Aug 15; 49(8):3299-304. PubMed ID: 18450595
    [Abstract] [Full Text] [Related]

  • 34. Effects of experimental ocular inflammation on ocular immune privilege.
    Ohta K, Wiggert B, Taylor AW, Streilein JW.
    Invest Ophthalmol Vis Sci; 1999 Aug 15; 40(9):2010-8. PubMed ID: 10440255
    [Abstract] [Full Text] [Related]

  • 35. Effects of CD8 depletion on retinal soluble antigen induced experimental autoimmune uveoretinitis.
    Calder VL, Zhao ZS, Wang Y, Barton K, Lightman SL.
    Immunology; 1993 Jun 15; 79(2):255-62. PubMed ID: 8102121
    [Abstract] [Full Text] [Related]

  • 36. Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism.
    Hoey S, Grabowski PS, Ralston SH, Forrester JV, Liversidge J.
    J Immunol; 1997 Nov 15; 159(10):5132-42. PubMed ID: 9366443
    [Abstract] [Full Text] [Related]

  • 37. The dynamics of leukocyte infiltration in experimental autoimmune uveoretinitis.
    Kerr EC, Copland DA, Dick AD, Nicholson LB.
    Prog Retin Eye Res; 2008 Sep 15; 27(5):527-35. PubMed ID: 18723108
    [Abstract] [Full Text] [Related]

  • 38. Immunohistochemical studies on the endotoxin-induced uveitis.
    Yang P, de Vos AF, Kijlstra A.
    Chin Med J (Engl); 1998 Mar 15; 111(3):252-6. PubMed ID: 10374428
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina.
    Dick AD, McMenamin PG, Körner H, Scallon BJ, Ghrayeb J, Forrester JV, Sedgwick JD.
    Eur J Immunol; 1996 May 15; 26(5):1018-25. PubMed ID: 8647162
    [Abstract] [Full Text] [Related]

  • 40. The distribution of immune cells in the uveal tract of the normal eye.
    McMenamin PG.
    Eye (Lond); 1997 May 15; 11 ( Pt 2)():183-93. PubMed ID: 9349410
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.